Jefferies Group LLC Intercept Pharmaceuticals, Inc. Call Options Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2019 Feb 13, 2020	BUY	$57.36 - $124.1 $3.34 Million - $7.22 Million	58,200 Added 55.91%	162,300 $20.1 Million
Q3 2019 Nov 13, 2019	BUY	$58.69 - $80.46 $6.05 Million - $8.3 Million	103,100 Added 10310.0%	104,100 $6.91 Million
Q1 2019 May 15, 2019	SELL	$91.83 - $120.68 $1.69 Million - $2.22 Million	-18,400 Reduced 94.85%	1,000 $112,000
Q4 2018 Feb 14, 2019	SELL	$85.79 - $126.46 $6.06 Million - $8.93 Million	-70,600 Reduced 78.44%	19,400 $1.96 Million
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $5.13 Million - $10.7 Million	90,000	90,000 $5.22 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.